Sandoz is investing 12 million euros in Kundl: Antibiotic production is growing!

Sandoz is investing 12 million euros in Kundl: Antibiotic production is growing!

in the Tyrolean Kundl, Sandoz causes a stir with an impressive investment of twelve million euros in the expansion of its production facilities! This decision will boost the production of a new broadband antibiotic that is effective against infections such as pneumonia and urinary tract infections. Stephanie Jedner, the plant manager, proudly explains: "We use our existing facilities and competence without having to build a new work." The annual production volume is increased to 4,400 tons, which is intended to strengthen the position of the company in Europe. This expansion will also help distribute the fixed costs better and to assert themselves against the competitors from Asia, as Jedner emphasizes.

groundbreaking production technology and security goals

The importance of these steps is underlined by the support of the federal and state governments, which together made a financial contribution of 50 million euros in order to protect the location of the location. This funding, together with the positive development of the production capacities, shows how crucial the production of antibiotics in Europe is. Despite earlier considerations of moving production to Asia, the return of to superior local production through innovations and technological progress has opened up new perspectives. The Kundl location remains not only a real hotspot for penicillin production, but also a symbol of future-oriented industrial strategies in Europe.